- Home
- BIOA
as 01-17-2025 4:00pm EST
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | RICHMOND |
| Market Cap: | 177.1M | IPO Year: | 2024 |
| Target Price: | $18.00 | AVG Volume (30 days): | 959.0K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -33.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.85 - $26.62 | Next Earning Date: | 02-15-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BioAge Labs Inc. Common Stock News
BIOA Breaking Stock News: Dive into BIOA Ticker-Specific Updates for Smart Investing
Zacks
17 days ago
BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Insider Monkey
23 days ago
BioAge Labs, Inc. (BIOA): A Bull Case Theory
Pharmaceutical Technology
a month ago
BioAge and Novartis seek drug targets for ageing-related diseases
MT Newswires
a month ago
BioAge Labs Says it is Partnering With Novartis to Identify Drug Targets to Treat Age-Related Diseases
GlobeNewswire
a month ago
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
Pharma Voice
a month ago
3 closely watched drugs that failed in the clinic
Clinical Trials Arena
a month ago
BioAge halts ongoing Phase II trial of obesity drug due to liver concerns
MT Newswires
a month ago
Top Premarket Decliners
Compare BIOA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BIOA BioAge Labs Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.